STUART DORMAN - 27 Feb 2025 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Commercial Officer
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Stuart Dorman
Issuer symbol
IDYA
Transactions as of
27 Feb 2025
Net transactions value
$0
Form type
4
Filing time
28 Feb 2025, 18:02:27 UTC
Previous filing
20 Dec 2024
Next filing
02 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 27 Feb 2025 Common Stock 15,000 $20.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.